NDC 59148-114 – Abilify Asimtufii
Aripiprazole 960 mg/3.2mL · Injection, Suspension, Extended Release · Intramuscular
Product NDC59148-114
Product details
- Brand name
- Abilify Asimtufii
- Generic name
- Aripiprazole
- Labeler
- Otsuka America Pharmaceutical, Inc
- Dosage form
- Injection, Suspension, Extended Release
- Route
- Intramuscular
- Marketing category
- NDA · NDA217006
- Marketed since
- April 27, 2023
- Listing expires
- December 31, 2026
- Pharmacologic class
- Atypical Antipsychotic
Active ingredients
- Aripiprazole 960 mg/3.2mL
Uses, dosage, side effects and warnings for Abilify Asimtufii →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 59148-114-80 | 1 SYRINGE in 1 CARTON (59148-114-80) / 3.2 mL in 1 SYRINGE | Apr 27, 2023 |
| 59148-114-92 sample | 1 SYRINGE in 1 CARTON (59148-114-92) / 3.2 mL in 1 SYRINGE | Apr 27, 2023 |
Other Abilify Asimtufii products
- 59148-102 Aripiprazole 720 mg/2.4mL · Injection, Suspension, Extended Release · Otsuka America Pharmaceutical, Inc